Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Kristin Wall ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4  
>>Next
 
Title
Country
Organisation
Author
Date
1
Government Releases Final Amendments To The PMPRB's Patented Medicines Regulations To Lower The Prices Of Patented Medicines
The Government is moving forward with changes to the PMPRB intended to lower the prices of patented medicines in Canada
Canada
15 Aug 2019
2
Federal Court Of Appeal Agrees That The PMPRB Incorrectly Applied The Patent-Pertaining Analysis
The Federal Court of Appeal has provided new guidance on the proper approach to the "patent pertaining" analysis used by the Patented Medicine Prices Review Board, including on the identification of the medicine ...
Canada
11 Jul 2019
3
CUSMA Implementation Bill Introduced
CUSMA provides more protections for biologic and innovative pharmaceuticals under Canadian law.
Canada
10 Jun 2019
5
Budget 2019: Federal Government Announces Intention To Implement Recommendations On National Pharmacare
Yesterday, the federal government announced funding to implement this recommendation.
Canada
22 Mar 2019
6
Interim Report On Implementation Of National Pharmacare Calls For Creation Of A National Drug Agency
As we reported, the Council consulted with Canadians on the implementation of a national program to fund prescription drugs.
Canada
13 Mar 2019
7
Health Canada Consulting On The Contents Of The Generic Submissions Under Review List
On January 7, 2019, Health Canada opened a consultation on whether to include the names of sponsor companies on the generic submissions under review list (GSUR) ...
Canada
31 Jan 2019
8
Top Headlines Of 2018
Last year ushered in a number of changes to the Canadian pharmaceutical and life sciences sector.
Canada
18 Jan 2019
9
Ontario Superior Court Rejects Apotex Attempts To Revive The Promise Doctrine By Dismissing Motion For Leave To Amend, Awards Substantial Indemnity Costs
The Ontario Superior Court of Justice (ONSC) recently denied Apotex's attempt to repackage the now defunct "promise of the patent" doctrine (the Promise Doctrine).
Canada
22 Nov 2018
10
New Protections For Biologics And Other Pharmaceuticals Under The United States-Mexico-Canada Agreement (USMCA)
As we reported, Canada has joined a new trilateral trade deal called the United States-Mexico-Canada Agreement (USMCA).
Canada
16 Oct 2018
11
Abbreviated New Drug Submissions Will Be Posted On The Submissions Under Review List And Other Pre-Market Transparency Initiatives
Health Canada recently published a notice outlining its phase III pre-market transparency initiatives for prescription drugs.
Canada
16 Oct 2018
12
CETA Tracker: Update On CSPs
To date, a total of 14 CSPs have been issued and three have been refused.
Canada
1 Oct 2018
13
Health Canada Releases Updated Guidance On Amended PM(NOC) Regulations
•The scope and application of section 5 of Regulations, including providing clarification for the types of submissions that will be captured by the provision when a second person applies for an NOC.
Canada
15 Aug 2018
15
First Motion For Early Patent Dismissal Fails To Meet High Burden Under Newly-Amended PM(NOC) Regulations
On July 6, 2018, the Federal Court dismissed the first motion brought under section 6.08 of the newly-amended Patented Medicines (Notice of Compliance) Regulations (the Regulations).
Canada
1 Aug 2018
16
Pan-Canadian Pharmaceutical Alliance (pCPA) Releases Draft Brand Process Guidelines
On June 13, 2018, the pan-Canadian Pharmaceutical Alliance (pCPA) released its draft Brand Process Guidelines (Guidelines) for stakeholder feedback.
Canada
21 Jun 2018
17
Standing Committee On Health Releases Report And Recommendations On National Pharmacare
On April 18, 2018 the Standing Committee on Health tabled its report on national pharmacare entitled Pharmacare Now: Prescription Medicine Coverage for All Canadians.
Canada
25 May 2018
18
CETA Tracker: Update On Section 6 Actions Under The Patented Medicines (Notice Of Compliance) Regulations
As we reported, Canada implemented a single-track pharmaceutical patent litigation regime through amendments to the Patented Medicines (Notice of Compliance) Regulations (the Regulations) on September 21, 2017.
Canada
25 May 2018
19
Apotex Request To Re-Open Validity Of Esomeprazole Patent Denied
The Federal Court dismissed Apotex's motion to re-open the validity phase of the patent infringement action relating to esomeprazole (AstraZeneca's NEXIUM®).
Canada
25 May 2018
20
Pharma In Brief - CETA Tracker: Patent Term Restoration Is Coming Soon To Canada – What You Need To Know Now
With Canada moving closer towards implementing the Comprehensive Economic and Trade Agreement (CETA), major reforms to Canada's Patent Act are coming soon, including the availability of Certificates of Supplementary Protection (CSPs): ..
Canada
5 May 2017
Links to Result pages
 
1 2 3 4  
>>Next